Low-dose angiotensin II reduces urinary cyclic AMP excretion in spontaneously hypertensive, but not normotensive, rats: Independence from hypertension and renal hemodynamic effects of angiotensin

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 1, 1999, Pages 115-123

  Jackson, Edwin K ^a,b   Herzer, William A ^a   Mi, Zaichuan ^a   Vyas, Subhash J ^a   Kost Jr , Curtis K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN; CAPTOPRIL; CYCLIC AMP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CYCLIC AMP URINE LEVEL; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; URINARY EXCRETION; URINE VOLUME;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CYCLIC AMP; FEMALE; HEMODYNAMIC PROCESSES; HYPERTENSION; KIDNEY; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0032822784     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Antonaccio MJ, Rubin B, Horovitz ZP, Laffan RJ, Goldberg ME, High JP, Harris DN and Zaidi I (1979) Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats. Jpn J Pharmacol 29:285-294.
2. Arendshorst WJ, Chatziantoniou C and Daniels FH (1990) Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int 30:S92-S96.
3. Bunkenburg B, Schnell C, Baum HP, Cumin F and Wood JM (1991) Prolonged angiotensin II antagonism in spontaneously hypertensive rats: Hemodynamic and biochemical consequences. Hypertension 18:278-288.
4. Campbell DJ, Duncan A-M, Kladis A and Harrap SB (1995) Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. Hypertension 25:928-934.
5. Chatziantoniou C and Arendshorst WJ (1991) Angiotensin and thromboxane in genetically hypertensive rats: Renal blood flow and receptor studies. Am J Physiol 261:F238-F247.
6. Chatziantoniou C and Arendshorst WJ (1992) Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol 263: F573-F580.
7. Chatziantoniou C, Daniels FH and Arendshorst WJ (1990) Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 259:F372-F382.
8. Chatziantoniou C, Ruan X and Arendshorst WJ (1993) Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol 265:F845-F852.
9. Chatziantoniou C, Ruan X and Arendshorst WJ (1995) Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 92:2924-2928.
10. Ferrone RA and Antonaccio MJ (1979) Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225). Eur J Pharmacol 60:131-137.
11. Hefti F, Fischli W and Gerold M (1986) Cilazapril prevents hypertension in spontaneously hypertensive rats. J Cardiovosc Pharmacol 8:641-648.
12. Jackson EK (1994) Pertussis toxin normalizes enhanced renovascular responses to angiotensin II in spontaneously hypertensive rats. Life Sci 54:PL445-PL450.
13. 2 interactions in spontaneously hypertensive rats. Hypertension 22:688-689.
14. Jackson EK and Herzer WA (1994) Defective modulation of angiotensin II-induced renal vasoconstriction in hypertensive rats. Hypertension 23:329-336.
15. Jackson EK and Li P (1997) Human leptin has natriuretic activity in the rat. Am J Physiol 272:F333-F338.
16. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr and Herzer WA (1996) Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther 279:1250-1260.
17. Koletsky S, Shook P and Rivera-Velez J (1970) Lack of increased renin-angiotensin activity in rats with spontaneous hypertension. Proc Soc Exp Biol Med 134:1187-1190.
18. Kost CK, Jr, Herzer WA, Li P and Jackson EK (1994) Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269:82-88.
19. Kost CK Jr and Jackson EK (1993) Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 21:420-431.
20. Kost CK Jr, Li P, Williams DS and Jackson EK (1998) Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats. J Cardiovasc Pharmacol 31:854-861.
21. Li P and Jackson EK (1989) Enhanced slow-pressor response to angiotensin II in the spontaneously hypertensive rat. J Pharmacol Exp Ther 251:909-921.
22. Mokkapatti R, Vyas SJ, Romero GG, Mi Z, Inoue T, Dubey RK, Gillespie DG, Stout AK and Jackson EK (1998) Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther 287:223-231.
23. Rettig R, Folberth CG, Graf C, Kopf D, Stauss H and Unger T (1991) Are renal mechanisms involved in primary hypertension? Evidence from kidney transplantation studies in rats. Klin Wochenschr 69:597-602.
24. Rettig R and Unger T (1991) The role of the kidney in the aetiology of hypertension: Renal transplantation studies in rats. Trends Pharmacol Sci 12:243-245.
25. Sen S, Smeby RR and Bumpus FM (1972) Renin in rats with spontaneous hypertension. Circ Res 31:876-880.
26. Shiono K and Sokabe H (1976) Renin-angiotensin system in spontaneously hypertensive rats. Am J Physiol 231:1295-1299.
27. Vyas SJ and Jackson EK (1995) Angiotensin II: Enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273:768-777.
28. Vyas SJ, Mi Z and Jackson EK (1996) The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J Pharmacol Exp Ther 279:114-119.
29. Wu J-N, Edwards D and Berecek KH (1994) Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril. Hypertension 23:819-822.